Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T09:06:17.714Z Has data issue: false hasContentIssue false
  • English
  • Français

On a meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease

Published online by Cambridge University Press:  21 March 2016

Yongbing Chen  and
Junbao Du
Yongbing Chen
Affiliation:
Department of Pediatrics, Peking University First Hospital, Beijing, China
Junbao Du*
Affiliation:
Department of Pediatrics, Peking University First Hospital, Beijing, China
*
Correspondence to: J. Du, Department of Pediatrics, Peking University First Hospital, Beijing 100034, China. E-mail: junbaodu1@126.com
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Reply
Information
Cardiology in the Young , Volume 26 , Issue 5 , June 2016 , pp. 1037
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Zhang, L, Chen, X. Comment on a meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease. Cardiol Young 2016, doi: 10.1017/S1047951116000172.CrossRefGoogle ScholarPubMed
2. Yang, X, Liu, G, Huang, Y, et al. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease. Cardiol Young 2015; 25: 1182–1190.CrossRefGoogle ScholarPubMed
3. Saneeymehri, S, Baker, K, So, T-Y. Overview of pharmacological treatment options for pediatric patients with refractory Kawasaki disease. J Pediatr Pharmacol Ther 2015; 20: 163–177.Google ScholarPubMed
4. Patel, RM, Shulman, ST. Kawasaki disease: a comprehensive review of treatment options. J Clin Pharm Ther 2015; 40: 620–625.CrossRefGoogle ScholarPubMed
5. Miura, M, Ohki, H, Yoshiba, S, et al. Adverse effects of methylprednisolone pulse therapy in refractory Kawasaki disease. Arch Dis Child 2005; 90: 1096–1097.CrossRefGoogle ScholarPubMed
6. Miura, M, Kohno, K, Ohki, H, Yoshiba, S, Sugaya, A, Satoh, M. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin. Eur J Pediatr 2008; 167: 1119–1123.CrossRefGoogle ScholarPubMed